Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREALGeneric

TRIVARIS

TRIAMCINOLONE ACETONIDE

Standard Dose
8MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TRIVARIS is listed in Drugs@FDA under application 022220 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TRIAMCINOLONE ACETONIDE Form and strength INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL - 8MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ALLERGAN Submission history Latest submission status date: 2008-06-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRIVARIS is listed in Drugs@FDA under application 022220 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TRIAMCINOLONE ACETONIDE Form and strength INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL - 8MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ALLERGAN Submission history Latest submission status date: 2008-06-16 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.